OpenAI turns to science with Rosalind
OpenAI has moved deeper into the scientific market with the launch of GPT-Rosalind, a specialist artificial intelligence model designed for biology, drug discovery and translational medicine, marking the company’s first dedicated push into life sciences as pharmaceutical groups and research institutes race to test whether advanced reasoning systems can shorten the slow and costly path from laboratory insight to new treatments. Announced on April 16, GPT-Rosalind is […]